Macquarie Group LTD Pfizer Inc Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Pfizer Inc stock. As of the latest transaction made, Macquarie Group LTD holds 5,710,297 shares of PFE stock, worth $160 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

5,710,297

Previous 5,218,467 9.42%

Holding current value

$160 Million

Previous $150 Million 5.47%

% of portfolio

0.18%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $12.7 Million - $14.6 Million	491,830 Added 9.42%	5,710,297 $158 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $686,722 - $891,977	-26,281 Reduced 0.5%	5,218,467 $150 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $18.5 Million - $21.6 Million	-576,756 Reduced 9.91%	5,244,748 $174 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $43 Million - $49.8 Million	1,191,243 Added 25.73%	5,821,504 $214 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $18.5 Million - $24.1 Million	469,856 Added 11.29%	4,630,261 $189 Million

Q4 2022 Feb 21, 2023	SELL	$41.75 - $54.5 $30.9 Million - $40.3 Million	-739,709 Reduced 15.1%	4,160,405 $213 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $19.8 Million - $24.2 Million	-453,528 Reduced 8.47%	4,900,114 $214 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $3.77 Million - $4.47 Million	-81,012 Reduced 1.49%	5,353,642 $281 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $45 Million - $55.8 Million	-983,867 Reduced 15.33%	5,434,654 $281 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $82.9 Million - $123 Million	2,006,883 Added 45.49%	6,418,521 $379 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $13.4 Million - $17.3 Million	-342,616 Reduced 7.21%	4,411,638 $190 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $4.48 Million - $5.08 Million	-124,850 Reduced 2.56%	4,754,254 $186 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $27.9 Million - $31.4 Million	831,643 Added 20.55%	4,879,104 $177 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $594 Million - $755 Million	-17,746,368 Reduced 81.43%	4,047,461 $149 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $36.2 Million - $42.5 Million	-1,140,819 Reduced 4.97%	21,793,829 $800 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $60.6 Million - $73.6 Million	-2,013,149 Reduced 8.07%	22,934,648 $750 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $40.1 Million - $57.4 Million	-1,484,982 Reduced 5.62%	24,947,797 $814 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $98.9 Million - $112 Million	3,005,472 Added 12.83%	26,432,779 $1.04 Billion
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $64.7 Million - $84 Million	1,992,715 Added 9.3%	23,427,307 $842 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $21.2 Million - $23.9 Million	-574,440 Reduced 2.61%	21,434,592 $929 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $4.82 Million - $5.3 Million	-128,535 Reduced 0.58%	22,009,032 $935 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $79.5 Million - $90.6 Million	-2,065,515 Reduced 8.53%	22,137,567 $966 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $39.2 Million - $47.5 Million	-1,137,080 Reduced 4.49%	24,203,082 $1.07 Billion
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $143 Million - $153 Million	4,344,595 Added 20.69%	25,340,162 $919 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $14.3 Million - $16.6 Million	449,273 Added 2.19%	20,995,567 $745 Million
Q4 2017 Feb 15, 2018	SELL	$33.26 - $35.29 $23 Million - $24.4 Million	-692,799 Reduced 3.26%	20,546,294 $743 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $658 Million - $725 Million	21,239,093	21,239,093 $758 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Pfizer Inc Transaction History